Elevated Pulmonary Artery Wedge Pressure in Group 1 Pulmonary Hypertension

Read full text
Authors: Yogesh N.V. Reddy, R Frantz, William R. Miranda, Aneesh K Asokan, Revati Varma, Franz Rischard, Paul M. Hassoun, Anna R. Hemnes, E. Horn, Jane A. Leopold, Erika B. Rosenzweig, N.S. Hill
+10 more Serpil C. Erzurum, Gerald J. Beck, John Barnard, J. Emanuel Finet, Deborah Kwon, Stephen C. Mathai, MONICA MUKHERJEE, Wen Tang, K. Sreekumaran Nair, Barry A. Borlaug
Cited by: 3
References: 50

Abstract

BACKGROUND: With pulmonary hypertension (PH), a pulmonary artery wedge pressure (PAWP)>15 mm Hg is used to diagnose left heart dysfunction, but some patients with adjudicated group 1 PH demonstrate PAWP>15 mm Hg. The primary objective of the study was to evaluate group 1 PH with high PAWP>15 mm Hg. METHODS: Patients with adjudicated group 1 PH from PVDOMICS between 2016 and 2019 were separated into high PAWP(>15 mm Hg) or normal PAWP and compared with adjudicated combined pre- and postcapillary (Cpc) PH related to heart failure with preserved ejection fraction (HFpEF). Participants underwent dynamic right heart catheterization and metabolomics. Findings were validated in 3 independent cohorts with adjudicated group 1 PH (validation cohorts 1 and 2 with exercise right heart catheterization and validation cohort 3 with resting right heart catheterization). RESULTS: Of 325 patients with group 1 PH (73% women, mean age 53.0±14.3 years), 15% (n=48) had high PAWP. Group 1 PH+high PAWP demonstrated greater obesity, left ventricular hypertrophy ( P

Fields of Study & Subjects

Pulmonary Hypertension Research and Treatments Cardiovascular Function and Risk Factors Cardiac Valve Diseases and Treatments

Publication details

Journal / source
Circulation
Publisher
Ovid Technologies (Wolters Kluwer Health)
Volume
153
Issue
13
Pages
948–962
Publication date
13 February 2026
Language
EN